TRex Bio, Inc. · NASDAQ:TRXB
Johnson & Johnson Innovation - JJDC, Inc. reported a 5.30% stake in TRex Bio, Inc. (Schedule 13G)
Event Oct 13, 2026 · Filed Oct 15, 2026
Johnson & Johnson Innovation - JJDC, Inc. reported a 5.30% stake in TRex Bio, Inc., 1,475,302 shares, as a passive investor on Oct 13, 2026. Filed Oct 15, 2026 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 1,475,302
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 5.30% | 1,475,302 |
| JOHNSON & JOHNSON | 5.30% | 1,475,302 |
Source
Download original · View original at SEC
Related
- TRex Bio, Inc.
- Johnson & Johnson Innovation - JJDC, Inc.
- TRex Bio, Inc. shareholders
- Schedule 13D · SV Biotech Crossover Opportunities Fund LP · Oct 16, 2026
- Schedule 13D · ELI LILLY & Co · Oct 16, 2026
- Schedule 13G · Pfizer Inc · Oct 16, 2026
- Form 4 · Alexandria Venture Investments, LLC · Oct 15, 2026
- Form 4 · Marcus Joel S · Oct 13, 2026